Catalyst Wire Dossier Catalyst Wire Dossier

New 6:2 Influenza Virus Reassortant Vaccine (bivalent)

· MedImmune LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for New 6:2 Influenza Virus Reassortant Vaccine (bivalent), covering 2007-12-18 to 2007-12-18. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults [Phase 3]

See pricing